Enkhtsetseg Purev

发表论文 90 篇 · 总被引 5591 次 · h-index 26

代表论文

• Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study (2020 · The Lancet · 被引 2421)
• Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia (2018 · Nature Medicine · 被引 831)
• Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology (2018 · Journal of the National Comprehensive Cancer Network · 被引 284)
• Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001 (2023 · Blood · 被引 189)
• Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL. (2018 · Journal of Clinical Oncology · 被引 168)
• Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia (2019 · Blood Advances · 被引 148)